UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 222

Sortiert nach

Advances in asthma and COPD management: Delivering CFC-free inhaled therapy using Modulite® technology

Pulmonary pharmacology & therapeutics, 2007-01, Vol.20 (3), p.290-303

2007

Volltextzugriff (PDF)

Comparative pulmonary toxicity assessment of pristine and functionalized multi-walled carbon nanotubes intratracheally instilled in rats: morphohistochemical evaluations

Histology and histopathology, 2011-03, Vol.26 (3), p.357

2011

Volltextzugriff (PDF)

Comparative in vitro and ex-vivo myelotoxicity of aflatoxins B1 and M1 on haematopoietic progenitors (BFU-E, CFU-E, and CFU-GM): Species-related susceptibility

Toxicology in vitro, 2010-02, Vol.24 (1), p.217-223

2010

Volltextzugriff (PDF)

Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent

Respiratory medicine, 2014-08, Vol.108 (8), p.1108-1116

2014

Volltextzugriff (PDF)

285 Pharmacokinetics of tobramycin nebulizer solution (Bramitob®) administered by Pari e-Flow Rapid vs Pari LC Plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection

Journal of cystic fibrosis, 2012-06, Vol.11, p.S129-S129

2012

Volltextzugriff (PDF)

Modulite® technology: pharmacodynamic and pharmacokinetic implications

Respiratory medicine, 2002-08, Vol.96, p.S9-S15

2002

Volltextzugriff (PDF)

D36 COPD: LABA, LAMA, ICS, AND COMBINATIONS: Pharmacokinetics Of A Novel Triple Fixed Dose Combination Metered Dose Inhaler: Comparison With The Free Combination And The Single Components

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers

Respiratory medicine, 2003-02, Vol.97 Suppl B, p.S5-S9

2003

Volltextzugriff (PDF)

Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo‐controlled, crossover study

British journal of clinical pharmacology, 2004-10, Vol.58 (4), p.359-366

2004

Volltextzugriff (PDF)

D37 COPD: DEVELOPMENTAL THERAPEUTICS: Safety, Tolerability And Pharmacokinetic Profile Of Chf6001, A Novel Selective Inhaled Pde4 Inhibitor, In Healthy Volunteers

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

D36 COPD: LABA, LAMA, ICS, AND COMBINATIONS: Effect Of Organic Cation Transport Inhibition On The Pharmacokinetics Of Glycopyrronium Bromide In Fixed Combination With Beclomethasone Dipropionate And Formoterol Fumarate

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healty male volunteers

Respiratory medicine, 2003-02, Vol.97, p.S5-S9

2003

Volltextzugriff (PDF)

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Sustained Efficacy Of Multiple Doses Of Extrafine Glycopyrronium Bromide In COPD Patients

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: A Single Dose Escalation Safety Study Of Extrafine Glycopyrronium Bromide Pmdi In COPD Patients

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Pharmacokinetics, Absolute Bioavailability And Lung Bioavailability Of Extrafine Inhaled Glycopyrronium Bromide Pmdi In Healthy Volunteers

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.2001-2014

2017

Volltextzugriff (PDF)

Comparative HPLC and ELISA studies for CDT isoform characterization in subjects with alcohol related problems. Prospective application in workplace risk-prevention policy

Giornale italiano di medicina del lavoro ed ergonomia, 2008-04, Vol.30 (2), p.119

2008

Volltextzugriff (PDF)

Influence of layer position on in vitro and in vivo release of levodopa methyl ester and carbidopa from three-layer matrix tablets

European journal of pharmaceutics and biopharmaceutics, 2002-03, Vol.53 (2), p.227-232

2002

Volltextzugriff (PDF)

FLUORESCEIN ASSISTANCE IN NEURO-ONCOLOGICAL SURGERY: A TREND OF THE MOMENT OR A REAL TECHNICAL ADJUNT?

Clinical neurology and neurosurgery, 2016-05, Vol.144, p.119-120

Acerbi, F., MD PhD

2016

Volltextzugriff (PDF)

Outcome in 157 alpha-amanitin-poisoned patients treated with the “Pavia protocol”

Toxicology letters, 2010-07, Vol.196, p.S91-S91

2010

Volltextzugriff (PDF)

Lungendeposition eines Formoterol-HFA-Dosieraerosols (Forair) bei Gesunden Probanden und Patienten mit Asthma und COPD

Pneumologie, 2006, Vol.60 (S 1)

2006

Volltextzugriff (PDF)

Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers: Nebulized Beclometasone Dipropionate Therapy in Asthma

Respiratory medicine, 2003, Vol.97, p.S5-S9

2003

Volltextzugriff (PDF)

Methylmercury interaction with lymphocyte cholinergic muscarinic receptors in developing rats

Environmental research, 2007-02, Vol.103 (2), p.229-237

2007

Volltextzugriff (PDF)

Comparative bioavailability of two oral formulations of ipriflavone in healthy volunteers at steady-state. Evaluation of two different dosage schemes

European journal of drug metabolism and pharmacokinetics, 1998-04, Vol.23 (2), p.172-177

1998

Volltextzugriff (PDF)

Clinical pharmacology study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi

Paediatric drugs, 2007, Vol.9 Suppl 1 (Supplement 1), p.3-9

2007

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(181)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Humans
(57)
Life Sciences & Biomedicine
(52)
Male
(50)
Physics Of Elementary Particles And Fields
(41)
Biological And Medical Sciences
(39)
Medical Sciences
(38)
Female
(34)
Pharmacology. Drug Treatments
(31)
Adult
(30)
Cross Sections
(30)
Physical Sciences
(27)
Physics
(27)
Luminosity
(26)
Technology
(26)
Animals
(25)
Production
(24)
Transverse Momentum
(24)
Decay
(23)
Pharmacology & Pharmacy
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advances in asthma and COPD management: Delivering CFC-free inhaled therapy using Modulite® technology

Comparative pulmonary toxicity assessment of pristine and functionalized multi-walled carbon nanotubes intratracheally instilled in rats: morphohistochemical evaluations

Comparative in vitro and ex-vivo myelotoxicity of aflatoxins B1 and M1 on haematopoietic progenitors (BFU-E, CFU-E, and CFU-GM): Species-related susceptibility

Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent

285 Pharmacokinetics of tobramycin nebulizer solution (Bramitob®) administered by Pari e-Flow Rapid vs Pari LC Plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection

Modulite® technology: pharmacodynamic and pharmacokinetic implications

D36 COPD: LABA, LAMA, ICS, AND COMBINATIONS: Pharmacokinetics Of A Novel Triple Fixed Dose Combination Metered Dose Inhaler: Comparison With The Free Combination And The Single Components

Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers

Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo‐controlled, crossover study

D37 COPD: DEVELOPMENTAL THERAPEUTICS: Safety, Tolerability And Pharmacokinetic Profile Of Chf6001, A Novel Selective Inhaled Pde4 Inhibitor, In Healthy Volunteers

D36 COPD: LABA, LAMA, ICS, AND COMBINATIONS: Effect Of Organic Cation Transport Inhibition On The Pharmacokinetics Of Glycopyrronium Bromide In Fixed Combination With Beclomethasone Dipropionate And Formoterol Fumarate

Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healty male volunteers

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Sustained Efficacy Of Multiple Doses Of Extrafine Glycopyrronium Bromide In COPD Patients

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: A Single Dose Escalation Safety Study Of Extrafine Glycopyrronium Bromide Pmdi In COPD Patients

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Pharmacokinetics, Absolute Bioavailability And Lung Bioavailability Of Extrafine Inhaled Glycopyrronium Bromide Pmdi In Healthy Volunteers

Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study

Comparative HPLC and ELISA studies for CDT isoform characterization in subjects with alcohol related problems. Prospective application in workplace risk-prevention policy

Influence of layer position on in vitro and in vivo release of levodopa methyl ester and carbidopa from three-layer matrix tablets

FLUORESCEIN ASSISTANCE IN NEURO-ONCOLOGICAL SURGERY: A TREND OF THE MOMENT OR A REAL TECHNICAL ADJUNT?

Outcome in 157 alpha-amanitin-poisoned patients treated with the “Pavia protocol”

Lungendeposition eines Formoterol-HFA-Dosieraerosols (Forair) bei Gesunden Probanden und Patienten mit Asthma und COPD

Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers: Nebulized Beclometasone Dipropionate Therapy in Asthma

Methylmercury interaction with lymphocyte cholinergic muscarinic receptors in developing rats

Comparative bioavailability of two oral formulations of ipriflavone in healthy volunteers at steady-state. Evaluation of two different dosage schemes

Clinical pharmacology study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi

Suchergebnisse filtern